CEREBAIN BIOTECH CORP. Contracts & Agreements
51 Contracts & Agreements
- Business Finance (36 contracts)
- Business Operations (3)
- Human Resources (7)
- Intellectual Property (1)
- Uncategorized (4)
- Form of 12% Convertible Promissory Note issued March 15, 2019, to Auctus Fund, LLC (Filed With SEC on April 5, 2019)
- Form of Securities Purchase Agreement dated March 15, 2019, by and between Cerebain Biotech Corp. and Auctus Fund, LLC (Filed With SEC on April 5, 2019)
- Form of Common Stock Purchase Warrant dated March 1, 2019, issued to Auctus Fund LLC (Filed With SEC on April 5, 2019)
- Form of Common Stock Purchase Warrant dated March 1, 2019, issued to Crown Bridge Partners, LLC (Filed With SEC on April 5, 2019)
- Form of Amendment to the Convertible Promissory Note issued March 26, 2019, to Auctus Fund LLC (Filed With SEC on April 5, 2019)
- Form of Amendment to the Convertible Promissory Note issued February 14, 2018, to Crown Bridge Partners, LLC (Filed With SEC on April 5, 2019)
- Securities Purchase Agreement dated December 10, 2018 (Filed With SEC on December 26, 2018)
- Convertible Promissory Note dated December 10, 2018 (Filed With SEC on December 26, 2018)
- Amended and Restated Warrant Agreement with EMA Financial dated February 15, 2018 (Filed With SEC on May 15, 2018)
- Securities Purchase Agreement between Cerebain Biotech Corp. and Crown Bridge Partners, LLC dated February 14, 2018 (Filed With SEC on March 13, 2018)
- Convertible Promissory Note issued to Crown Bridge Partners, LLC dated February 14, 2018 (Filed With SEC on March 13, 2018)
- Common Stock Purchase Warrant issued to Crown Bridge Partners, LLC dated February 14, 2018 (Filed With SEC on March 13, 2018)
- Securities Purchase Agreement between Cerebain Biotech Corp. and Auctus Fund, LLC dated February 15, 2018 (Filed With SEC on March 13, 2018)
- Convertible Promissory Note issued to Auctus Fund, LLC dated February 15, 2018 (Filed With SEC on March 13, 2018)
- Common Stock Purchase Warrant issued to Auctus Fund, LLC dated February 15, 2018 (Filed With SEC on March 13, 2018)
- Securities Purchase Agreement between Cerebain Biotech Corp. and EMA Financial, LLC dated February 12, 2018 (Filed With SEC on March 13, 2018)
- Convertible Promissory Note issued to EMA Financial, LLC dated February 12, 2018 (Filed With SEC on March 13, 2018)
- Common Stock Purchase Warrant issued to EMA Financial, LLC dated February 12, 2018 (Filed With SEC on March 13, 2018)
- Stock Purchase Agreement with Stockholder dated February 1, 2018 (Filed With SEC on February 6, 2018)
- Employment Agreement with Eric Clemons dated February 1, 2018 (Filed With SEC on February 6, 2018)
- Employment Agreement with Wesley Tate dated February 1, 2018 (Filed With SEC on February 6, 2018)
- $2,460,000 Amended and Consolidated Promissory Note date January 24, 2017 (Filed With SEC on May 11, 2017)
- $2,410,000 Amended and Consolidated Promissory Note dated November 22, 2016 (Filed With SEC on February 10, 2017)
- $2,285,000 Amended and Consolidated Promissory Note dated August 1, 2016 (Filed With SEC on November 14, 2016)
- EMPLOYMENT AGREEMENT (Filed With SEC on November 16, 2015)
- AMENDED AND CONSOLIDATED CONVERTIBLE PROMISSORY NOTE $1,345,000 May 28, 2014 Dallas, TX (Filed With SEC on August 11, 2014)
- DEBT CONVERSION AND STOCK PURCHASE AGREEMENT (Filed With SEC on August 11, 2014)
- $1,245,000 February 25, 2014 Dallas, TX (Filed With SEC on May 14, 2014)
- EXHIBIT 10.21CEREBAIN BIOTECH CORP. (Filed With SEC on February 10, 2014)
- AMENDED AND CONSOLIDATED CONVERTIBLE PROMISSORY NOTE $970,000 October 15, 2013 Dallas, TX (Filed With SEC on February 10, 2014)
- DEBT CONVERSION AND STOCK PURCHASE AGREEMENT (Filed With SEC on January 6, 2014)
- DEBT CONVERSION AND STOCK PURCHASE AGREEMENT (Filed With SEC on January 6, 2014)
- EMPLOYMENT AGREEMENT (Filed With SEC on September 30, 2013)
- EMPLOYMENT AGREEMENT (Filed With SEC on September 30, 2013)
- Consulting Agreement (Filed With SEC on September 30, 2013)
- CEREBAIN BIOTECH CORP. CONSULTING AGREEMENT (Filed With SEC on September 30, 2013)
- Advertising Contract (Filed With SEC on August 15, 2013)
- AMENDED AND CONSOLIDATEDCONVERTIBLE PROMISSORY NOTE (Filed With SEC on May 3, 2013)
- AMENDED AND CONSOLIDATED PROMISSORY NOTE $235,000November 1, 2012Irvine, CA (Filed With SEC on February 12, 2013)
- TERMINATION AGREEMENT AND GENERAL RELEASE (Filed With SEC on January 24, 2013)
- TERMINATION AGREEMENT AND GENERAL RELEASE (Filed With SEC on January 24, 2013)
- TERMINATION AGREEMENT AND GENERAL RELEASE (Filed With SEC on January 24, 2013)
- PROMISSORY NOTE (Filed With SEC on January 24, 2013)
- PROMISSORY NOTE (Filed With SEC on January 24, 2013)
- PROMISSORY NOTE (Filed With SEC on January 24, 2013)
- CONVERTIBLE PROMISSORY NOTE $240,000June 18, 2012 Irvine, CA (Filed With SEC on November 14, 2012)
- Page 1 of 6 (Filed With SEC on September 28, 2012)
- SHARE EXCHANGE AGREEMENT (Filed With SEC on February 10, 2012)
- ASSIGNMENT AND ASSUMPTION AGREEMENT (Filed With SEC on February 10, 2012)
- STOCK PURCHASE AGREEMENT (Filed With SEC on February 10, 2012)
- PATENT LICENSE AGREEMENT (Filed With SEC on February 10, 2012)